NCT01851551View on ClinicalTrials.gov

Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2005

Conditions
Non-Hodgkin's LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma
Interventions
DRUG

Vincristine Sulfate Liposome Injection plus rituximab

Trial Locations (2)

94110

University of California, San Francisco

LS1 3EX

Leeds General Infirmary, Leeds

Sponsors
All Listed Sponsors
lead

Acrotech Biopharma Inc.

INDUSTRY